Thus, carriers of path_MLH1 or path_MSH2, who have a higher risk of developing CRC, would theoretically derive a greater benefit from total colectomy compared to carriers of the low-risk variants (path_MSH6 and path_PMS2), in which colonoscopic surveillance might achieve an efficient prophylaxis (Table 1). The gene discussed is PMS2; the disease is colorectal carcinoma.